The U.S. Food and Drug Administration is working with Deerfield, Ill.-based Baxter Healthcare, Evanston, Ill.-based B. Braun Medical and Lake Forest, Ill.-based Hospira to address the issue, according to the news release.
More Articles on the FDA:
FDA Bans Ranbaxy Laboratories From Manufacturing, Importing Drugs
FDA Drug Approval Processes Not Consistent
FDA Appoints Dr. Rafael Miguel to Anesthetic and Analgesic Drug Products Advisory Committee
